Royal Bank of Canada’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-959
| Closed | – | – | 7888 |
|
|
2023
Q2 | $0 | Buy |
959
+61
| +7% | +$11 | ﹤0.01% | 7882 |
|
|
2023
Q1 | $0 | Sell |
898
-43
| -5% | -$19 | ﹤0.01% | 7693 |
|
|
2022
Q4 | $0 | Buy |
941
+36
| +4% | +$31 | ﹤0.01% | 7998 |
|
|
2022
Q3 | $1K | Sell |
905
-238
| -21% | -$257 | ﹤0.01% | 7346 |
|
|
2022
Q2 | $0 | Sell |
1,143
-4,235
| -79% | -$3.25K | ﹤0.01% | 7938 |
|
|
2022
Q1 | $6K | Sell |
5,378
-14,306
| -73% | -$17.1K | ﹤0.01% | 7221 |
|
|
2021
Q4 | $45K | Buy |
19,684
+9,826
| +100% | +$24.7K | ﹤0.01% | 6436 |
|
|
2021
Q3 | $34K | Buy |
9,858
+3,798
| +63% | +$11.7K | ﹤0.01% | 6389 |
|
|
2021
Q2 | $18K | Sell |
6,060
-7,995
| -57% | -$25.3K | ﹤0.01% | 6628 |
|
|
2021
Q1 | $45K | Buy |
14,055
+13,820
| +5,881% | +$46.1K | ﹤0.01% | 5962 |
|
|
2020
Q4 | $0 | Sell |
235
-766
| -77% | -$1.26K | ﹤0.01% | 7377 |
|
|
2020
Q3 | $1K | Sell |
1,001
-200
| -17% | -$205 | ﹤0.01% | 6515 |
|
|
2020
Q2 | $1K | Buy |
1,201
+163
| +16% | +$155 | ﹤0.01% | 6520 |
|
|
2020
Q1 | $1K | Buy |
1,038
+347
| +50% | +$402 | ﹤0.01% | 6534 |
|
|
2019
Q4 | $0 | Sell |
691
-105
| -13% | -$115 | ﹤0.01% | 7226 |
|
|
2019
Q3 | $1K | Buy |
796
+596
| +298% | +$812 | ﹤0.01% | 6555 |
|
|
2019
Q2 | $0 | Hold |
200
| – | – | ﹤0.01% | 7299 |
|
|
2019
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 7202 |
|
|
2018
Q4 | $0 | Sell |
200
-114
| -36% | -$205 | ﹤0.01% | 7257 |
|
|
2018
Q3 | $1K | Sell |
314
-386
| -55% | -$799 | ﹤0.01% | 6632 |
|
|
2018
Q2 | $1K | Buy |
+700
| New | +$1.41K | ﹤0.01% | 6413 |
|
|
2018
Q1 | – | Sell |
-227
| Closed | – | – | 6931 |
|
|
2017
Q4 | $0 | Sell |
227
-1,273
| -85% | -$2.64K | ﹤0.01% | 7012 |
|
|
2017
Q3 | $2K | Hold |
1,500
| – | – | ﹤0.01% | 6576 |
|
|
2017
Q2 | $2K | Sell |
1,500
-2,121
| -59% | -$4.09K | ﹤0.01% | 6309 |
|
|
2017
Q1 | $11K | Sell |
3,621
-1,197
| -25% | -$2.94K | ﹤0.01% | 5937 |
|
|
2016
Q4 | $6K | Buy |
4,818
+3,202
| +198% | +$4.18K | ﹤0.01% | 6258 |
|
|
2016
Q3 | $2K | Hold |
1,616
| – | – | ﹤0.01% | 6213 |
|
|
2016
Q2 | $2K | Buy |
+1,616
| New | +$7.56K | ﹤0.01% | 6174 |
|
|
2015
Q3 | – | Sell |
-19,418
| Closed | -$212K | – | 6842 |
|
|
2015
Q2 | $212K | Buy |
19,418
+13,918
| +253% | +$179K | ﹤0.01% | 4319 |
|
|
2015
Q1 | $77K | Sell |
5,500
-35,067
| -86% | -$536K | ﹤0.01% | 4747 |
|
|
2014
Q4 | $685K | Buy |
40,567
+3,000
| +8% | +$43.7K | ﹤0.01% | 3264 |
|
|
2014
Q3 | $504K | Sell |
37,567
-400
| -1% | -$4.76K | ﹤0.01% | 3464 |
|
|
2014
Q2 | $483K | Buy |
37,967
+32,017
| +538% | +$334K | ﹤0.01% | 3437 |
|
|
2014
Q1 | $71K | Buy |
5,950
+700
| +13% | +$9.39K | ﹤0.01% | 4704 |
|
|
2013
Q4 | $73K | Buy |
5,250
+2,588
| +97% | +$36.5K | ﹤0.01% | 4740 |
|
|
2013
Q3 | $46K | Sell |
2,662
-3,155
| -54% | -$60.4K | ﹤0.01% | 4852 |
|
|
2013
Q2 | $94K | Buy |
+5,817
| New | +$180K | ﹤0.01% | 4342 |
|
Other funds holding INFI
Royal Bank of Canada's INFI Position: Q3 2023 in Review
Royal Bank of Canada sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 959 shares.
Royal Bank of Canada first reported a position in INFI in Q2 2013 and held it in 37 quarters. The position peaked at $685K in Q4 2014. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Royal Bank of Canada reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Royal Bank of Canada sold 959 Infinity Pharmaceuticals, Inc. shares in Q3 2023.
- Royal Bank of Canada first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 37 quarters.
- Royal Bank of Canada's Infinity Pharmaceuticals, Inc. position peaked at $685K in Q4 2014.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.